Ozempic Is Changing More Than Waistlines as Scientists Wise Up to Concerning Side Effects
But GLP-1 drugs also offer many benefits beyond weight loss.
Visualizing the Top Emerging Technologies of 2025
See this visualization first on the Voronoi app. Use This Visualization Visualizing the Top 10 Emerging Tech of 2025 This was originally posted on our Voronoi app. Download the app for free on iOS or Android and discover incredible data-driven charts from a variety of trusted sources. Key Takeaways Structural battery composites and collaborative sensing […]
Can Mounjaro and Zepbound Drive Another Strong Quarter for Eli Lilly?
Demand for Eli Lilly’s LLY blockbuster GLP-1 medicines — Mounjaro (for type II diabetes) and Zepbound (for obesity) — remains strong. Despite being on the market for less than three years, both drugs have become the company’s key top-line drivers. In the first quarter of 2025, they generated combined sales of $6.15 billion, accounting for […]
Potential of non-digestible polysaccharides as GLP-1 secretagogues: action mechanisms, structure-activity relationships and clinical applications
Publication date: 1 November 2025 Source: Carbohydrate Polymers, Volume 367 Author(s): Zhen-Zi Shang, Hui-Yu Ye, Qiang-Ming Li, Xue-Qiang Zha, Jian-Ping Luo